当前位置：
X-MOL 学术
›
Cancer Biol. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2023-11-30 , DOI: 10.1080/15384047.2023.2285801 Tingyu Yu 1 , Qian Zhan 2 , Xinyu Yan 1 , Xiaohua Luo 1 , Xin Wang 1 , Xiaoqiong Tang 1 , Hongbin Zhang 1 , Zesong Yang 1 , Jianbin Chen 1 , Lin Liu 1 , Li Wang 1
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2023-11-30 , DOI: 10.1080/15384047.2023.2285801 Tingyu Yu 1 , Qian Zhan 2 , Xinyu Yan 1 , Xiaohua Luo 1 , Xin Wang 1 , Xiaoqiong Tang 1 , Hongbin Zhang 1 , Zesong Yang 1 , Jianbin Chen 1 , Lin Liu 1 , Li Wang 1
Affiliation
To explore the clinical significance and prognosis of acute myeloid leukemia (AML) patients with WT1 mutations.In total, the clinical data of 269 adult patients with non-M3 AML were considered retr...
中文翻译：
WT1在评估非M3急性髓系白血病疗效及预后中的临床意义
探讨WT1突变的急性髓系白血病（AML）患者的临床意义和预后。总共考虑了269例成年非M3 AML患者的临床数据。
更新日期：2023-12-02
中文翻译：
WT1在评估非M3急性髓系白血病疗效及预后中的临床意义
探讨WT1突变的急性髓系白血病（AML）患者的临床意义和预后。总共考虑了269例成年非M3 AML患者的临床数据。
京公网安备 11010802027423号